On July 31, 2025, US President Donald Trump signed an executive order to adjust reciprocal tariff rates, setting the provisional tariff for Taiwan at 20%, effective from August 7, 2025. According to senior government officials in Taiwan, relief measures have been initiated, and affected businesses are urged to apply within the stipulated timeframe. For traditional industries, China faces tariffs exceeding 50% on related goods, which provides Taiwan with a competitive opportunity to gain market recognition.

Diva Laboratories, a medical display manufacturer under Qisda Group, has joined the supply chain of Royal Philips and received the company’s “Procurement Innovation Partner Health Systems” award. The firm generates over 80% of its revenue from international customers.

Taiwan President Ching-Te Lai stressed the importance of defense autonomy during his speech at the “2025 Taiwan Venture Capital Summit” on August 12, 2025. He stated that Taiwan has no intention of changing the status quo but must strengthen its national defense.